Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

A rare case of pulmonary lepidic metastasis in patient with branch-type intraductal papillary mucinous carcinoma of the pancreas.

Sakuma F, Tsuchida K, Minaguchi T, Nagashima K, Izawa N, Jinnai H, Sugaya T, Tominaga K, Goda K, Iijima M, Machida H, Kuroda H, Irisawa A.

Clin J Gastroenterol. 2019 May 23. doi: 10.1007/s12328-019-00993-9. [Epub ahead of print]

PMID:
31123981
2.

Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer.

Shikama A, Minaguchi T, Takao W, Hosokawa Y, Nishida K, Tasaka N, Akiyama A, Sakurai M, Ochi H, Satoh T.

Int J Clin Oncol. 2019 Oct;24(10):1256-1263. doi: 10.1007/s10147-019-01469-z. Epub 2019 May 16.

PMID:
31098693
3.

Human papillomavirus genotype and prognosis of cervical cancer: Favorable survival of patients with HPV16-positive tumors.

Onuki M, Matsumoto K, Tenjimbayashi Y, Tasaka N, Akiyama A, Sakurai M, Minaguchi T, Oki A, Satoh T, Yoshikawa H.

Papillomavirus Res. 2018 Dec;6:41-45. doi: 10.1016/j.pvr.2018.10.005. Epub 2018 Oct 19.

4.

Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin.

Lachkar B, Minaguchi T, Akiyama A, Liu S, Zhang S, Xu C, Shikama A, Tasaka N, Sakurai M, Nakao S, Ochi H, Yoshikawa H, Satoh T.

Medicine (Baltimore). 2018 Aug;97(31):e11392. doi: 10.1097/MD.0000000000011392.

5.

Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.

Liu S, Minaguchi T, Lachkar B, Zhang S, Xu C, Tenjimbayashi Y, Shikama A, Tasaka N, Akiyama A, Sakurai M, Nakao S, Ochi H, Onuki M, Matsumoto K, Yoshikawa H, Satoh T.

PLoS One. 2018 Feb 21;13(2):e0193061. doi: 10.1371/journal.pone.0193061. eCollection 2018.

6.

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

Saito T, Tabata T, Ikushima H, Yanai H, Tashiro H, Niikura H, Minaguchi T, Muramatsu T, Baba T, Yamagami W, Ariyoshi K, Ushijima K, Mikami M, Nagase S, Kaneuchi M, Yaegashi N, Udagawa Y, Katabuchi H.

Int J Clin Oncol. 2018 Apr;23(2):201-234. doi: 10.1007/s10147-017-1193-z. Epub 2017 Nov 20.

7.

Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402).

Hirakawa T, Minaguchi T, Itani Y, Kasamatsu Y, Murase S, Sakurada S, Nagano H, Takehara K, Tsuruta T, Arakawa A, Kawano K, Tsubamoto H, Ushiwaka T, Mori T, Iwai K, Saito M, Morisawa H, Saito F, Yoshida K, Kaneuchi M, Sato H, Ito K, Nasu K.

World J Surg Oncol. 2017 Jul 17;15(1):132. doi: 10.1186/s12957-017-1200-x.

8.

Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma.

Nishida K, Tenjimbayashi Y, Tasaka N, Shikama A, Sakuraiv M, Nakao S, Ochi H, Minaguchi T, Satoh T.

Int Cancer Conf J. 2016 Nov 24;6(2):50-54. doi: 10.1007/s13691-016-0271-9. eCollection 2017 Apr.

9.

Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism.

Sakurai M, Matsumoto K, Gosho M, Sakata A, Hosokawa Y, Tenjimbayashi Y, Katoh T, Shikama A, Komiya H, Michikami H, Tasaka N, Akiyama-Abe A, Nakao S, Ochi H, Onuki M, Minaguchi T, Yoshikawa H, Satoh T.

Int J Gynecol Cancer. 2017 Jan;27(1):37-43. doi: 10.1097/IGC.0000000000000848.

10.

Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas.

Shikama A, Minaguchi T, Matsumoto K, Akiyama-Abe A, Nakamura Y, Michikami H, Nakao S, Sakurai M, Ochi H, Onuki M, Satoh T, Oki A, Yoshikawa H.

Gynecol Oncol. 2016 Feb;140(2):226-33. doi: 10.1016/j.ygyno.2015.11.032. Epub 2015 Nov 28.

PMID:
26644264
11.

Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.

Minaguchi T, Satoh T, Matsumoto K, Sakurai M, Ochi H, Onuki M, Oki A, Yoshikawa H.

Int J Clin Oncol. 2016 Jun;21(3):573-9. doi: 10.1007/s10147-015-0910-8. Epub 2015 Oct 16.

PMID:
26475355
12.

Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.

Onuki M, Matsumoto K, Sakurai M, Ochi H, Minaguchi T, Satoh T, Yoshikawa H.

J Gynecol Oncol. 2016 Jan;27(1):e3. doi: 10.3802/jgo.2016.27.e3. Epub 2015 Oct 8.

13.

High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension.

Sakurai M, Satoh T, Matsumoto K, Michikami H, Nakamura Y, Nakao S, Ochi H, Onuki M, Minaguchi T, Yoshikawa H.

Int J Gynecol Cancer. 2015 May;25(4):593-8. doi: 10.1097/IGC.0000000000000415.

14.

Optimizing biopsy procedures during colposcopy for women with abnormal cervical cancer screening results: a multicenter prospective study.

Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, Endo S, Nagai K, Oki A, Minaguchi T, Morishita Y, Noguchi M, Yoshikawa H.

Int J Clin Oncol. 2015 Jun;20(3):579-85. doi: 10.1007/s10147-014-0739-6. Epub 2014 Aug 22.

PMID:
25145298
15.

Therapeutic effect of dienogest on adenosarcoma arising from endometriosis: a case report.

Tasaka N, Matsumoto K, Satoh T, Minaguchi T, Onuki M, Ochi H, Tanaka YO, Sakata A, Noguchi M, Yoshikawa H.

Springerplus. 2013 Nov 20;2:618. doi: 10.1186/2193-1801-2-618. eCollection 2013.

16.

Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas.

Akiyama-Abe A, Minaguchi T, Nakamura Y, Michikami H, Shikama A, Nakao S, Sakurai M, Ochi H, Onuki M, Matsumoto K, Satoh T, Oki A, Yoshikawa H.

Br J Cancer. 2013 Sep 17;109(6):1703-10. doi: 10.1038/bjc.2013.455. Epub 2013 Aug 15.

17.

Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment.

Satoh T, Matsumoto K, Tanaka YO, Akiyama A, Nakao S, Sakurai M, Ochi H, Onuki M, Minaguchi T, Sakurai H, Yoshikawa H.

Thromb Res. 2013 Apr;131(4):e127-32. doi: 10.1016/j.thromres.2013.01.027. Epub 2013 Feb 20.

PMID:
23433998
18.

The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia.

Ichinose M, Fujimoto A, Osuga Y, Minaguchi T, Kawana K, Yano T, Kozuma S.

Int J Gynecol Cancer. 2013 Feb;23(2):288-93. doi: 10.1097/IGC.0b013e31827c18a1.

PMID:
23314282
19.

PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma.

Abe A, Minaguchi T, Ochi H, Onuki M, Okada S, Matsumoto K, Satoh T, Oki A, Yoshikawa H.

Hum Pathol. 2013 Feb;44(2):199-207. doi: 10.1016/j.humpath.2012.05.005. Epub 2012 Sep 3.

PMID:
22955107
20.

Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity reactions in gynecologic malignancies.

Michikami H, Minaguchi T, Ochi H, Onuki M, Okada S, Matsumoto K, Satoh T, Oki A, Yoshikawa H.

J Obstet Gynaecol Res. 2013 Jan;39(1):330-5. doi: 10.1111/j.1447-0756.2012.01893.x. Epub 2012 May 28.

PMID:
22640034
21.

[Investigating language acquisition disorders based on the complaints].

Tamanaha AC, Oshiro LT, Kawano CE, Okumura M, Ghiringhelli R, Minaguchi T, Rosa LA, Sanchez M, Perissinoto J.

J Soc Bras Fonoaudiol. 2011;23(2):124-38. Portuguese.

PMID:
21829927
22.

Villin1, a diagnostic marker for endometrial adenocarcinoma with high grade nuclear atypia.

Nakamura E, Satoh T, Iwakawa M, Nakawatari M, Oki A, Matsumoto K, Okada S, Minaguchi T, Yoshikawa H, Imai T.

Cancer Biol Ther. 2011 Aug 1;12(3):181-90. Epub 2011 Aug 1.

PMID:
21623163
23.

Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women.

Matsumoto K, Oki A, Satoh T, Okada S, Minaguchi T, Onuki M, Ochi H, Nakao S, Sakurai M, Abe A, Hamada H, Yoshikawa H.

Jpn J Clin Oncol. 2010 Nov;40(11):1113-6. doi: 10.1093/jjco/hyq094. Epub 2010 Jun 17.

PMID:
20558465
24.

[Molecular mechanism of cervical carcinogenesis].

Minaguchi T, Yoshikawa H.

Gan To Kagaku Ryoho. 2010 Jan;37(1):18-22. Review. Japanese.

PMID:
20087029
25.

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer.

Onuki M, Matsumoto K, Satoh T, Oki A, Okada S, Minaguchi T, Ochi H, Nakao S, Someya K, Yamada N, Hamada H, Yoshikawa H.

Cancer Sci. 2009 Jul;100(7):1312-6. doi: 10.1111/j.1349-7006.2009.01161.x. Epub 2009 Apr 22.

26.

Silent venous thromboembolism before treatment in endometrial cancer and the risk factors.

Satoh T, Matsumoto K, Uno K, Sakurai M, Okada S, Onuki M, Minaguchi T, Tanaka YO, Homma S, Oki A, Yoshikawa H.

Br J Cancer. 2008 Oct 7;99(7):1034-9. doi: 10.1038/sj.bjc.6604658. Epub 2008 Sep 9.

27.

Analysis of the status of the novel estrogen receptor α (ERα) coactivator p72 in endometrial cancer and its cross talk with erbB-2 in the transactivation of ERα.

Zhao L, Watanabe M, Yano T, Yanagisawa J, Nakagawa S, Oishi H, Wada-Hiraike O, Oda K, Minaguchi T, Yasugi T, Kato S, Taketani Y.

Mol Med Rep. 2008 May-Jun;1(3):387-90.

PMID:
21479421
28.

Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer.

Tsuruga T, Nakagawa S, Watanabe M, Takizawa S, Matsumoto Y, Nagasaka K, Sone K, Hiraike H, Miyamoto Y, Hiraike O, Minaguchi T, Oda K, Yasugi T, Yano T, Taketani Y.

Oncol Res. 2007;16(9):431-5.

PMID:
18074678
30.

Human homolog of Drosophila tumor suppressor Scribble negatively regulates cell-cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells.

Nagasaka K, Nakagawa S, Yano T, Takizawa S, Matsumoto Y, Tsuruga T, Nakagawa K, Minaguchi T, Oda K, Hiraike-Wada O, Ooishi H, Yasugi T, Taketani Y.

Cancer Sci. 2006 Nov;97(11):1217-25. Epub 2006 Sep 5.

31.

Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium.

Minaguchi T, Nakagawa S, Takazawa Y, Nei T, Horie K, Fujiwara T, Osuga Y, Yasugi T, Kugu K, Yano T, Yoshikawa H, Taketani Y.

Cancer Lett. 2007 Apr 8;248(1):112-22. Epub 2006 Aug 21.

PMID:
16919866
32.

The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation.

Chung JH, Ostrowski MC, Romigh T, Minaguchi T, Waite KA, Eng C.

Hum Mol Genet. 2006 Sep 1;15(17):2553-9. Epub 2006 Jul 18.

PMID:
16849370
33.

Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.

Matsumoto Y, Nakagawa S, Yano T, Takizawa S, Nagasaka K, Nakagawa K, Minaguchi T, Wada O, Ooishi H, Matsumoto K, Yasugi T, Kanda T, Huibregtse JM, Taketani Y.

J Med Virol. 2006 Apr;78(4):501-7.

PMID:
16482544
34.

Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix.

Minaguchi T, Yoshikawa H, Nakagawa S, Yasugi T, Yano T, Iwase H, Mizutani K, Shiromizu K, Ohmi K, Watanabe Y, Noda K, Nishiu M, Nakamura Y, Taketani Y.

Cancer Lett. 2004 Jul 8;210(1):57-62.

PMID:
15172121
35.

Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas.

Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M, Kawana K, Minaguchi T, Oda K, Hasumi Y, Taketani Y.

Cancer Lett. 2002 Jun 6;180(1):83-9.

PMID:
11911974
36.

PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas.

Minaguchi T, Yoshikawa H, Oda K, Ishino T, Yasugi T, Onda T, Nakagawa S, Matsumoto K, Kawana K, Taketani Y.

Clin Cancer Res. 2001 Sep;7(9):2636-42.

37.

Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.

Matsushima-Nishiu M, Unoki M, Ono K, Tsunoda T, Minaguchi T, Kuramoto H, Nishida M, Satoh T, Tanaka T, Nakamura Y.

Cancer Res. 2001 May 1;61(9):3741-9.

38.

A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas.

Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, Kanamori Y, Minaguchi T, Nakamura Y, Tokino T, Kudo R.

Jpn J Cancer Res. 2000 Jun;91(6):612-5.

39.

Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.

Minaguchi T, Mori T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y, Nakamura Y.

Cancer Res. 1999 Dec 15;59(24):6063-7.

40.

Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region.

Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, Terakawa N, Nakamura Y.

Cancer Res. 1999 Sep 1;59(17):4225-7.

41.

Complete DNA sequence and characterization of a 330-kb VNTR-rich region on chromosome 6q27 that is commonly deleted in ovarian cancer.

Minaguchi T, Matsushima M, Saito S, Kanamori Y, Shirahama S, Okamoto S, Minami M, Taketani Y, Nakamura Y.

DNA Res. 1999 Apr 30;6(2):131-6.

PMID:
10382971
42.

No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.

Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y, Nakamura Y.

Cancer Res. 1998 Oct 15;58(20):4585-6.

43.

Complete genomic structure DNA polymorphisms, and alternative splicing of the human AF-6 gene.

Saito S, Matsushima M, Shirahama S, Minaguchi T, Kanamori Y, Minami M, Nakamura Y.

DNA Res. 1998 Apr 30;5(2):115-20.

PMID:
9679199
44.

Isolation, mapping, and functional analysis of a novel human cDNA (BNIP3L) encoding a protein homologous to human NIP3.

Matsushima M, Fujiwara T, Takahashi E, Minaguchi T, Eguchi Y, Tsujimoto Y, Suzumori K, Nakamura Y.

Genes Chromosomes Cancer. 1998 Mar;21(3):230-5.

PMID:
9523198
45.

Identification of minute fragment of bone by X-ray microanalysis.

Ikemoto S, Takaesu Y, Miyake B, Minaguchi T, Araki A.

Bull Tokyo Dent Coll. 1976 May;17(2):67-71. No abstract available.

PMID:
1076066

Supplemental Content

Loading ...
Support Center